glp-1 pipeline Timeline of discovery and clinical development. (a) Key events in Emerging Trends in the Development

GLP 1 shot is for adults with obesity (BMI 30) or overweight (excess weight) (BMI 27) who also have weight-related medical problems to help them lose weight and keep it off

Citations Citations to this article as recorded by Anti-inflammatory effect of glucagon-like Peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model Yeon Woong Chung, Ji Young Lee, Hyun Hee Ju, Jin A

GIMOTI is not recommended for use in: Pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates

When body fat percentage drops below certain thresholds, the brain may temporarily suppress reproductive hormone production, leading to irregular or absent periods

Designed for daily use at home or on the go

A GLP-1 agonist is a type of medication that mimics a hormone our bodies naturally produce: GLP-1 (glucagon-like peptide-1)